Table 1. Levels of DCD expression in primary tissue and cell lines for each organ site.
Dermcidin expression level
|
|||||||||
---|---|---|---|---|---|---|---|---|---|
Number of samples
|
Number of samples
|
||||||||
Organ | Benign | Cancer | Cell line | Sample type: benign, cancer or cell line | Very high (%) | High (%) | Moderate (%) | Low/absent (%) | Not detected/below the limits of detection (%) |
Oesophagus | 5a | 28 | 0 | Benign: | 0 | 0 | 0 | 0 | 5 (100) |
Cancer: | 0 | 0 | 0 | 4 (14.3) | 24 (85.7) | ||||
Stomach | 5a | 20 | 0 | Benign: | 0 | 0 | 0 | 0 | 5 (100) |
Cancer: | 0 | 0 | 2 (10) | 3 (15) | 15 (75) | ||||
Pancreas | 2b | 5 | 2 | Benign: | 0 | 0 | 0 | 0 | 2 (100) |
Cancer: | 0 | 2 (40) | 1 (20) | 0 | 2 (40) | ||||
Cell Line: | 0 | 0 | 1 (50) | 1 (50) | 0 | ||||
Bile duct | 0 | 1 | 0 | Cancer: | 0 | 1 (100) | 0 | 0 | 0 |
Prostate | 16c | 52 | 4 | Benign: | 0 | 0 | 0 | 0 | 16 (100) |
Cancer: | 0 | 0 | 0 | 0 | 52 (100) | ||||
Cell Line: | 0 | 0 | 0 | 3 (75) | 1 (25) | ||||
Others | 2d | 1e | 0 | Benign: | 0 | 0 | 0 | 0 | 2 (100) |
Cancer: | 0 | 0 | 0 | 1 (100) | 0 |
Benign samples taken during normal upper gastrointestinal endoscopy examinations.
Chronic pancreatitis samples.
Benign prostatic hypertrophy samples.
Pancreatic liposarcoma and adenoma.
Pancreatic cystadenoma.